Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease.

Suppr

超能文献

作者信息

Dyminski J W, Daoud A, Lampkin B C, Limouze S, Donofrio J, Coleman M S, Hutton J J

出版信息

Clin Immunol Immunopathol. 1979 Nov;14(3):307-26. doi: 10.1016/0090-1229(79)90157-0.

DOI:10.1016/0090-1229(79)90157-0

PMID:498598

Abstract

摘要

相似文献

Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease.

Clin Immunol Immunopathol. 1979 Nov;14(3):307-26. doi: 10.1016/0090-1229(79)90157-0.

Effect of adenosine deaminase replacement therapy on a child of adenosine deaminase deficiency with severe combined immunodeficiency disease.腺苷脱氨酶替代疗法对一名患有严重联合免疫缺陷病的腺苷脱氨酶缺乏症患儿的疗效。

Tohoku J Exp Med. 1979 Jul;128(3):251-8. doi: 10.1620/tjem.128.251.

Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.红细胞输注、胸腺激素和脱氧胞苷对腺苷脱氨酶缺乏所致重症联合免疫缺陷的影响。

Clin Exp Immunol. 1982 Nov;50(2):303-10.

Severe combined immunodeficiency disease with adenosine deaminase deficiency.伴有腺苷脱氨酶缺乏的重症联合免疫缺陷病

Tohoku J Exp Med. 1979 Oct;129(2):197-202. doi: 10.1620/tjem.129.197.

Iron overload as a result of transfusion therapy in a patient with adenosine deaminase deficiency.腺苷脱氨酶缺乏症患者因输血治疗导致铁过载。

Nebr Med J. 1985 Mar;70(3):95-7.

In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes.胸腺素和腺苷脱氨酶对腺苷脱氨酶缺陷淋巴细胞的体内和体外作用。

N Engl J Med. 1979 Feb 22;300(8):387-92. doi: 10.1056/NEJM197902223000802.

Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.酶替代疗法及其他治疗腺苷脱氨酶缺乏症的生化方法。

Ciba Found Symp. 1978(68):213-30. doi: 10.1002/9780470720516.ch14.

Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency.腺苷脱氨酶缺乏症和严重联合免疫缺陷的酶替代疗法。

N Engl J Med. 1976 Dec 9;295(24):1337-43. doi: 10.1056/NEJM197612092952402.

Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency.红细胞和血浆输注对腺苷脱氨酶缺乏症的疗效有限。

J Pediatr. 1978 Oct;93(4):597-603. doi: 10.1016/s0022-3476(78)80894-4.

ADA and PNP deficiencies: how it all began.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏症：一切的开端

Ann N Y Acad Sci. 1985;451:1-8. doi: 10.1111/j.1749-6632.1985.tb27090.x.

引用本文的文献

Heterozygous Mutation in Adenosine Deaminase Gene in a Patient With Severe Lymphopenia Following Corticosteroid Treatment of Autoimmune Hemolytic Anemia.一名自身免疫性溶血性贫血患者在接受皮质类固醇治疗后出现严重淋巴细胞减少，其腺苷脱氨酶基因存在杂合突变。

Front Pediatr. 2018 Oct 1;6:272. doi: 10.3389/fped.2018.00272. eCollection 2018.

Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID).聚乙二醇化牛腺苷脱氨酶（PEG-ADA）用于治疗重症联合免疫缺陷（SCID）的婴幼儿。

Biologics. 2009;3:349-58. Epub 2009 Jul 13.

Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.腺苷脱氨酶缺乏症患者在酶替代治疗期间淋巴细胞的生化及功能异常

J Clin Invest. 1981 Aug;68(2):413-21. doi: 10.1172/jci110270.

Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.腺苷脱氨酶缺乏所致重症联合免疫缺陷的病理表现。I. 肾脏、肾上腺及软骨-骨组织改变。

Am J Pathol. 1985 Jul;120(1):157-69.

Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.通过逆转录病毒介导的基因转移纠正培养的人T细胞和B细胞中的腺苷脱氨酶缺乏症。

Proc Natl Acad Sci U S A. 1986 Sep;83(17):6563-7. doi: 10.1073/pnas.83.17.6563.

Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.腺苷脱氨酶缺乏型重症联合免疫缺陷的病理发现。II. 胸腺、脾脏、淋巴结及胃肠道淋巴组织改变

Am J Pathol. 1989 Dec;135(6):1145-56.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验